West Cattle Securities: Maintains "Buy" rating on CStone Pharmaceuticals (03931.HK) with target price raised to HK$29.5.

According to the Wise Finance APP, West Cattle Securities released a research report stating that, driven by economies of scale and cost reduction, it maintains a positive profit forecast for China Innovation Air (03931.HK), maintains a "buy" rating, and raises the target price to HK$29.50 per share. The group has raised its shipment volume forecast for next year, and both the new projects of power batteries and the demand for energy storage batteries have provided support for the group. Particularly, the group's energy storage batteries are currently in short supply, and after the release of production capacity, they will be able to make a greater contribution to the group. In terms of cost reduction, the group's input-output ratio and yield rate have significantly improved, offsetting the impact of increased R&D expenses.